Profile: CollaGenex Pharmaceuticals, acquired by Galderma USA is a specialty pharmaceutical company, which focuses on providing innovative medical therapies for dermatological diseases.We produce dermatological applications of its proprietary Impacs™ technology. Oracea™ has completed Phase III clinical trials for the treatment of the inflammatory lesions of rosacea. We also create additional products for dermatology based on Restoraderm ®, a novel drug delivery technology.